Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 9238512, 12 pages
http://dx.doi.org/10.1155/2016/9238512
Research Article

Effects of Extracts from Tiaozhi Granule and Its Components on Expression of Scavenger Receptor Class B Type I

1Laboratory of Cancer Molecular Genetics, Medical College of Soochow University, Dushu Lake Campus, 199 Ren-Ai Road, Suzhou Industrial Park, Suzhou 215123, China
2Department of Internal Medicine, The Affiliated Suzhou Chinese Traditional Medicine Hospital, Nanjing University of Chinese Medicine, 18 Yang-Su Road, Suzhou 215003, China
3Department of Physiology, Medical College of Soochow University, Dushu Lake Campus, 199 Ren-Ai Road, Suzhou Industrial Park, Suzhou 215123, China

Received 2 September 2016; Revised 23 October 2016; Accepted 20 November 2016

Academic Editor: Kuzhuvelil B. Harikumar

Copyright © 2016 Xiao Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Fisher, “Regression of atherosclerosis: the journey from the liver to the plaque and back,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 2, pp. 226–232, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Hegele, S. S. Gidding, H. N. Ginsberg et al., “Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement from ATVB Council,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 11, pp. 2269–2280, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Spence, “Recent advances in pathogenesis, assessment, and treatment of atherosclerosis,” F1000Research, vol. 5, 2016. View at Publisher · View at Google Scholar
  4. J. G. Robinson and N. J. Stone, “The 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk: a new paradigm supported by more evidence,” European Heart Journal, vol. 36, no. 31, pp. 2110–2118, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Lloyd-Jones, D. C. Goff, and N. J. Stone, “Treatment of blood cholesterol to reduce risk for atherosclerotic cardiovascular disease,” Annals of Internal Medicine, vol. 164, no. 2, pp. 135–136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. M.-J. Van Rooy and E. Pretorius, “Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events,” Current Medicinal Chemistry, vol. 21, no. 19, pp. 2121–2129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Wang, M. Gao, J. Liao et al., “Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids, vol. 1861, no. 5, pp. 410–418, 2016. View at Publisher · View at Google Scholar
  8. S. S. Gidding, M. A. Champagne, S. D. de Ferranti et al., “The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association,” Circulation, vol. 132, no. 22, pp. 2167–2192, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kunze and B. Schwarz, “[Epidemiology of atherosclerosis and disorders of lipid metabolism],” Wiener Medizinische Wochenschrift, vol. 140, no. 4, pp. 94–100, 1990. View at Google Scholar · View at Scopus
  10. J. D. Barth and A. C. Arntzenius, “Progression and regression of atherosclerosis, what roles for LDL-cholesterol and HDL-cholesterol: a perspective,” European Heart Journal, vol. 12, no. 8, pp. 952–957, 1991. View at Google Scholar · View at Scopus
  11. J. R. Downs, M. Clearfield, S. Weis et al., “Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study,” The Journal of the American Medical Association, vol. 279, no. 20, pp. 1615–1622, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Acton, A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Kriegert, “Identification of scavenger receptor SR-BI as a high density lipoprotein receptor,” Science, vol. 271, no. 5248, pp. 518–520, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Watanabe, H. Fujii, T. Takahashi et al., “Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity,” The Journal of Biological Chemistry, vol. 275, no. 29, pp. 22293–22299, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Zanoni, S. A. Khetarpal, D. B. Larach et al., “Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease,” Science, vol. 351, no. 6278, pp. 1166–1171, 2016. View at Google Scholar
  15. S. S. Varpe, A. R. Juvekar, M. P. Bidikar, and P. R. Juvekar, “Evaluation of anti-inflammatory activity of Typha angustifolia pollen grains extracts in experimental animals,” Indian Journal of Pharmacology, vol. 44, no. 6, pp. 788–791, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Selvam, L. Subramanian, R. Gayathri, and N. Angayarkanni, “The anti-oxidant activity of turmeric (Curcuma longa),” Journal of Ethnopharmacology, vol. 47, no. 2, pp. 59–67, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Tian, H. Chen, and Y.-Y. Zhao, “Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.) Juzep: a review,” Journal of Ethnopharmacology, pp. 373–387, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Fukata, X. Yu, H. Imachi et al., “17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells,” Endocrine, vol. 46, no. 3, pp. 644–650, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Dong, J.-W. Chen, L.-L. Tian et al., “Role of the renin-angiotensin system, renal sympathetic nerve system, and oxidative stress in chronic foot shock-induced hypertension in rats,” International Journal of Biological Sciences, vol. 11, no. 6, pp. 652–663, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. X. R. Xi and S. X. Li, “[Analysis on contents of flavonoids and polysaccharides in pollen of Typha angustifolia L. and its different processed products],” China Journal of Chinese Materia Medica, vol. 25, no. 1, pp. 25–28, 2000. View at Google Scholar · View at Scopus
  21. F. Qin and H.-X. Sun, “Immunosuppressive activity of Pollen Typhae ethanol extract on the immune responses in mice,” Journal of Ethnopharmacology, vol. 102, no. 3, pp. 424–429, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Ohkura, K. Tamura, A. Tanaka, J. Matsuda, and G.-I. Atsumi, “Experimental study on the hemostatc activity of Pollen Typhae: a traditional folk medicine used by external and oral application,” Blood Coagulation & Fibrinolysis, vol. 22, no. 8, pp. 631–636, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. A. Sardar, Z.-U. Khan, A. Perveen, S. Farid, and I. U. Khan, “In vitro antioxidant potential and free radical scavenging activity of various extracts of pollen of Typha domigensis Pers,” Pakistan Journal of Pharmaceutical Sciences, vol. 27, no. 2, pp. 279–284, 2014. View at Google Scholar · View at Scopus
  24. X.-T. Feng, Q. Chen, Z. Xie et al., “Pollen Typhae total flavone improves insulin resistance in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats,” Bioscience, Biotechnology and Biochemistry, vol. 78, no. 10, pp. 1738–1742, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Xu, B.-S. Ku, H.-Y. Yao et al., “The effects of curcumin on depressive-like behaviors in mice,” European Journal of Pharmacology, vol. 518, no. 1, pp. 40–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. B. B. Aggarwal, C. Sundaram, N. Malani, and H. Ichikawa, “Curcumin: the Indian solid gold,” in The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, vol. 595 of Advances in Experimental Medicine and Biology, pp. 1–75, Springer, Berlin, Germany, 2007. View at Publisher · View at Google Scholar
  27. T. W. Corson and C. M. Crews, “Molecular understanding and modern application of traditional medicines: triumphs and trials,” Cell, vol. 130, no. 5, pp. 769–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-T. Tu, Q.-Y. Yao, B.-L. Xu, J.-Y. Wang, C.-H. Zhou, and S.-C. Zhang, “Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression,” Food and Chemical Toxicology, vol. 50, no. 9, pp. 3343–3351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Y. Lee, S. W. Kim, G. H. Lee et al., “Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation,” BMC Complementary and Alternative Medicine, vol. 16, article 316, 2016. View at Publisher · View at Google Scholar
  30. J. Xu, Y. Fu, and A. Chen, “Activation of peroxisome proliferator-activated receptor-γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 285, no. 1, pp. G20–G30, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Li, S. Jin, C. Song et al., “The metabolic change of serum lysophosphatidylcholines involved in the lipid lowering effect of triterpenes from Alismatis rhizoma on high-fat diet induced hyperlipidemia mice,” Journal of Ethnopharmacology, vol. 177, pp. 10–18, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Dai, L. L. Zhong, Y. Cao et al., “Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial,” Trials, vol. 17, no. 1, 2016. View at Publisher · View at Google Scholar
  33. N. Wang, W. Weng, J. L. Breslow, and A. R. Tall, “Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control,” The Journal of Biological Chemistry, vol. 271, no. 35, pp. 21001–21004, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. D. K. Spady, D. M. Kearney, and H. H. Hobbs, “Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster,” Journal of Lipid Research, vol. 40, no. 8, pp. 1384–1394, 1999. View at Google Scholar · View at Scopus